JASN, the flagship journal of the ASN, publishes original research reports and basic and clinical science papers relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by JASN EIC, Josie Briggs, and the editorial fellows, each episode gives a behind the scenes look into the conception of the latest journal articles. New episodes monthly.
Intensive BP Control and CKD Progression and Prognosis in Anti-GBM Disease
9:43In the March podcast, Dr. Briggs discusses a study that addresses prognostic measures in Anti-GBM Disease and a meta-analysis of studies testing whether intensive blood pressure controls slows progression of CKD.
Pregnancy Risk for Kidney Patients; Cost Effectiveness Research in Dialysis
11:44In this Podcast, Dr. Briggs summarizes the goals of the new JASN Special Series, Health Policy Catalyst, and summarizes papers focusing on cost effectiveness research in nephrology and on the special risk of unwanted pregnancies for kidney patients.
Ne ratez aucun épisode de “Journal of the American Society of Nephrology (JASN)” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Use of Kidney Organoids to Study Steroid-Resistant Nephrotic Syndrome
19:33In this podcast, Dr. Briggs discusses organoid studies with author Dr. Melissa Little. The work explores the varied molecular mechanisms of specific mutations that cause SRNS and suggests promise for eventual design of mutation-specific treatments.
Gender Differences in Care of CKD Patients
11:32In this podcast, JASN EIC, Josie Briggs talks with Juan-Jesus Carrero, Professor of Kidney Disease Epidemiology at Karolinska Institute. His study, published in the October issue of JASN, documents striking differences in care of men and women with CKD.
Climate Change: Implications for Nephrology
7:43In this episode we cover two papers that examine the impact of climate change on nephrology practice. Specifically, the effect of extreme weather events on hemodialysis patient mortality and greenhouse gas emissions associated with dialysis treatment.
August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension
8:54Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.
Addressing Racial and Ethnic Disparities in Kidney Disease
20:34In this podcast, Dr. Briggs and JASN Deputy Editor, Dr. Donald Wesson discuss the special series highlighted in the July Issue. The series focuses on kidney health disparities with an emphasis on strategies for their elimination.
Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?
6:05Dr. Briggs summarizes findings in a study published in the June issue of JASN. The study examines the impact of continued immunosuppression in patients with failed allografts; the effects are surprising and suggest current guidelines may not be optimum.